Log In
Print
BCIQ
Print
Print this Print this
 

APX002

  Manage Alerts
Collapse Summary General Information
Company Apexigen Inc.
DescriptionHumanized mAb which inhibits interleukin-1-beta
Molecular Target Interleukin-1 (IL-1) beta
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation

Partner

Jiangsu T-mab BioPharma Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today